Clinical Trials Directory

Trials / Completed

CompletedNCT03228342

Ultrasound Impact in Rheumatoid Arthritis Patient Reported Outcomes

The Impact of Musculoskeletal Ultrasound-added to Clinical Evaluations- on Patient Reported Outcomes: A Prospective Study of Rheumatoid Arthritis Patients Classified in Remission/Low Disease Activity (ULTRAPRO)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
94 (actual)
Sponsor
Clínica de Artritis Temprana · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Evaluate the impact of MusculoSkeletal Ultrasound added to Rheumatoid Arthritis patients classified in remission/low disease activity in terms of Patient Reported Outcomes.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMusculoSkeletal UltrasoundPatient will be assess with ultrasound (GUS-7 score) and the results will be informed to his/her attending Rheumatologist. The Patient Reported Outcomes will be evaluated a 0,6 and 12 months after randomization.
DIAGNOSTIC_TESTMusculoSkeletal UltrasoundPatient will be assess with ultrasound (GUS-7 score) and the results will not be informed to his/her attending Rheumatologist. The Patient Reported Outcomes will be evaluated a 0,6 and 12 months after randomization.

Timeline

Start date
2017-05-03
Primary completion
2019-01-28
Completion
2019-01-28
First posted
2017-07-24
Last updated
2019-01-30

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT03228342. Inclusion in this directory is not an endorsement.